| Financial Year |
March 31 2023 |
| Monetary Funds |
2,986,344,302.40 |
| Held-for-trading Financial Assets |
816,186,272.31 |
| Notes Receivable |
751,008,591.35 |
| Accounts Receivable |
1,616,314,943.72 |
| Advances to Suppliers |
548,934,316.46 |
| Other Receivables |
195,721,967.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,025,000.00 |
| Inventories |
3,318,483,652.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,639,997.66 |
| Total Current Assets |
10,620,688,723.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
960,226,907.47 |
| Investment Properties |
31,889,904.86 |
| Fixed Assetes |
1,785,129,697.31 |
| Under-construction Projects |
53,788,482.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
500,267.00 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
559,938,036.42 |
| R&D expenses |
20,172,510.94 |
| Goodwill |
340,177,842.60 |
| Long-Term Deferred and Prepaid Expenses |
6,734,225.12 |
| Deferred Income Tax Assets |
189,312,153.87 |
| Other Non-Current Assets |
213,667,250.66 |
| Sub-Total of Non-Current Assets |
4,576,839,590.28 |
| Total Assets |
15,197,528,314.27 |
| Short-Term Loans |
287,291,438.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
229,943,527.82 |
| Accounts Payable |
775,328,684.92 |
| Accounts Received In Advance |
178,570.00 |
| Employee Compensation Payable |
90,826,677.48 |
| Taxes Payable |
209,721,002.55 |
| Interest Payable |
-- |
| Dividend Payable |
361,263.00 |
| Other payables |
267,058,370.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
164,235,878.08 |
| Other Current Liabilities |
440,464,224.44 |
| Sub-Total of Current Liabilities |
2,569,765,035.08 |
| Long-term Loans |
391,459,245.85 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
37,203,447.65 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
74,578,428.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
709,354,919.10 |
| Total Liabilities |
3,279,119,954.18 |
| Paid-In Capital(Or Share Stock) |
1,152,562,520.00 |
| Capital Surplus |
2,727,425,218.63 |
| Surplus Reserve |
188,152,423.13 |
| LESS:Treasury Stock |
364,293,598.94 |
| Undistributed Profits |
7,427,403,372.62 |
| Minority Stockholder's Interest |
451,538,342.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,466,870,017.59 |
| Owner's Equity（Stockholder's Equity） |
11,918,408,360.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,197,528,314.27 |
